Concepedia

Author

O. S. Weislow

National Cancer Institute

Also Known As

O S Weislow, O Weislow, O. S. Weislow, O.S. Weislow, OWEN S. WEISLOW, Owen S Weislow, Owen S. Weislow, Owen Weislow, Weislow, Owen S.

61

Publications

3.6K

Citations

22

H-Index

74

Concepts

All Affiliations

National Cancer InstituteWalter Reed Army Institute of ResearchSA Technologies (United States)Southern Research InstituteNational Institutes of Health
OS

About

O. S. Weislow is an author at National Cancer Institute specializing in medicine, immunology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

24

2K

2

Natural Sciences

6

6

558

3

Allergy

3

3

51

4

Biochemistry

3

3

203

5

Engineering

2

2

31

O. S. Weislow

×

33

Publications

3.4K

Citations

21

H-Index

YearCitations

New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity

O. S. Weislow, Rebecca Kiser, Donald L. Fine,

JNCI Journal of the National Cancer Institute

1989

689

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

John R. Mascola, S W Snyder, O. S. Weislow,

The Journal of Infectious Diseases

1996

433

AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae)

Kirk R. Gustafson, John H. Cardellina, Richard W. Fuller,

JNCI Journal of the National Cancer Institute

1989

299

Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitro

Robert Vince, Hua Mei, Jay Brownell,

Biochemical and Biophysical Research Communications

1988

231

Antiviral Effect and Ex Vivo CD4 <sup>+</sup> T Cell Proliferation in HIV-Positive Patients as a Result of CD28 Costimulation

Bruce L. Levine, Joseph D. Mosca, James L. Riley,

Science

1996

220

A nonpromoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1

Kirk R. Gustafson, John H. Cardellina, James B. McMahon,

Journal of Medicinal Chemistry

1992

214

Differential Regulation of HIV-1 Fusion Cofactor Expression by CD28 Costimulation of CD4 <sup>+</sup> T Cells

Richard G. Carroll, James L. Riley, Bruce L. Levine,

Science

1997

205

Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission.

G. Fang, Harold Burger, Roger Grimson,

Proceedings of the National Academy of Sciences

1995

174

Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase

James B. McMahon, Robert J. Gulakowski, O. S. Weislow,

Antimicrobial Agents and Chemotherapy

1993

129

Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.

Paul M. Hoffman, Suhayl Dhib‐Jalbut, Judy A. Mikovits,

Proceedings of the National Academy of Sciences

1992

107

Page 1